Back to Agenda
Session 6: Resources for Patient Engagement Metrics
Session Chair(s)
Elizabeth Lincoln, MA
HR Consultant
CCI Consulting, United States
With increasing interest – and investment – in patient centricity, there are corresponding efforts to develop approaches for implementing patient-centric practice and tools for assessing the effectiveness and impact on drug development. Presenters in this session will introduce three tools and the work behind developing them. These tools help organizations navigate the development of their own patient-centric practices, help teams define, quantify, and evaluate the impact of their patient-centric efforts, and provide drug developers with quantifiable measures of various patient-centric activities on areas such as cost, speed, quality, and study participant impact.
Learning Objective :
Speaker(s)
Speaker
Elizabeth Lincoln, MA
CCI Consulting, United States
HR Consultant
Speaker
Rebecca Ashkenazy, MD
Pfizer, Inc., United States
US Men's & Women's Health Medical Affairs Lead, Pfizer Essential Health
Speaker
Mary Jo Lamberti, PhD, MA
Tufts Center for the Study of Drug Development, United States
Director of Sponsored Research, Research Associate Professor
Have an account?